Thyroid-associated Orbitopathy: Quantitative Evaluation of the Orbital Fat Volume and Edema Using IDEAL-FSE

[1]  Y. Akiyama,et al.  Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy , 2016, American Journal of Neuroradiology.

[2]  W. Wiersinga,et al.  Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon. , 2015, European journal of endocrinology.

[3]  K. Sugino,et al.  Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study. , 2015, The Journal of clinical endocrinology and metabolism.

[4]  B. Alfano,et al.  Semiautomatic Regional Segmentation to Measure Orbital Fat Volumes in Thyroid-Associated Ophthalmopathy , 2013, The neuroradiology journal.

[5]  Zhi-jia Fang,et al.  CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy. , 2013, International journal of ophthalmology.

[6]  Y. Akiyama,et al.  Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of multiple myeloma: initial clinical efficiency results , 2012, European Radiology.

[7]  Ronald M. Mancini,et al.  Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy. , 2012, Archives of ophthalmology.

[8]  J. Xian,et al.  Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity , 2012, Acta radiologica.

[9]  K. Nayak,et al.  Comparison of Fat–Water MRI and Single‐voxel MRS in the Assessment of Hepatic and Pancreatic Fat Fractions in Humans , 2010, Obesity.

[10]  M. Nardi,et al.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. , 2008, European journal of endocrinology.

[11]  L. Røhl,et al.  Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. , 2006, Acta ophthalmologica Scandinavica.

[12]  P. Goddard,et al.  Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. , 2006, European journal of radiology.

[13]  P. Goddard,et al.  Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease , 2005 .

[14]  G. Lennerstrand,et al.  Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  G. Lennerstrand,et al.  MRI measurements of orbital tissues in dysthyroid ophthalmopathy , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  G. Kahaly,et al.  Imaging in thyroid-associated orbitopathy. , 2001, European journal of endocrinology.

[17]  F. Zonneveld,et al.  The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy , 2001, Clinical endocrinology.

[18]  H. Hoshi,et al.  Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements. , 1994, Radiology.

[19]  J. Rootman,et al.  The initial clinical characteristics of Graves' orbitopathy vary with age and sex. , 1993, Archives of ophthalmology.

[20]  J. Silber,et al.  Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. , 1986, AJR. American journal of roentgenology.

[21]  S. Feldon,et al.  Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy. , 1985, Archives of ophthalmology.

[22]  B. Tengroth.  HISTOLOGICAL STUDIES OF ORBITAL TISSUES IN A CASE OF ENDOCRINE EXOPHTHALMOS BEFORE AND AFTER REMISSION , 1964, Acta ophthalmologica.

[23]  J. Beyer,et al.  Plasma glycosaminoglycans in endocrine ophthalmopathy , 1994, Journal of endocrinological investigation.

[24]  大西 隆.  Extraocular muscles in graves ophthalmopathy : Usefulness of T2 relaxation time measurements , 1994 .

[25]  D. Glinoer,et al.  Original acquisition in the pathogenesis and the treatment of endocrine ophthalmopathy. , 1988, Metabolic, pediatric, and systemic ophthalmology.